No Data
No Data
Market Chatter: Genmab CEO Says Western Firms Should Tap Into China's 'Impressive Innovation'
Express News | Genmab Announces Presentation Of Multiple Abstracts On Epcoritamab At 2024 European Hematology Association Congress On June 13-16, 2024
Genmab to Present New and Updated Results From Multiple Clinical Trials Evaluating Epcoritamab Across Various B-Cell Malignancies at the 2024 European Hematology Association (EHA) Congress
Media ReleaseCOPENHAGEN, Denmark; May 14, 2024 Sixteen abstracts accepted for presentation and publication demonstrate depth and breadth of comprehensive epcoritamab development programThree oral pres
Express News | Watching Genmab; Shares Trading Higher After Novo Nordisk Announced Results From The FRONTIER 2 Trial In People Aged 12 Years Or Older With Haemophilia A
Genmab A/S Details Capital and Corporate Structure
6-K: Report of foreign private issuer (related to financial reporting)